- $409.81m
- $252.30m
- $41.29m
- 56
- 24
- 66
- 47
REG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Confirmation of Board change
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - CEO Transition and Revenue Guidance Update
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Total Voting Rights
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
AnnouncementRCS - MaxCyte, Inc. - MaxCyte Joins the Alliance for mRNA Medicines
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Filing of Form 10-Q
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Third Quarter Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Participation in Upcoming Investor Conferences
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Total Voting Rights
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Preliminary Q3 Revenue & FY Revenue Guidance
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Total Voting Rights
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementRCS - MaxCyte, Inc. - Appointment of Executive VP of Bioprocessing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
Announcement